1622204-15-2

Basic information

• Product Name: 6-ethoxy-5-((2-(4-(1-ethylpiperidin-4-yl)benzamide)pyridin-4-yl)oxy)-N-methyl-1H-indole-1-carboxamide
• Synonyms: 6-ethoxy-5-((2-(4-(1-ethylpiperidin-4-yl)benzamide)pyridin-4-yl)oxy)-N-methyl-1H-indole-1-carboxamide
• CAS NO: 1622204-15-2
• Molecular Weight: 541.65
• Mol File: 1622204-15-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-ethoxy-5-((2-(4-(1-ethylpiperidin-4-yl)benzamide)pyridin-4-yl)oxy)-N-methyl-1H-indole-1-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 6-ethoxy-5-((2-(4-(1-ethylpiperidin-4-yl)benzamide)pyridin-4-yl)oxy)-N-methyl-1H-indole-1-carboxamide(1622204-15-2)
• EPA Substance Registry System: 6-ethoxy-5-((2-(4-(1-ethylpiperidin-4-yl)benzamide)pyridin-4-yl)oxy)-N-methyl-1H-indole-1-carboxamide(1622204-15-2)

Safety Data

• Hazardous Substances Data: 1622204-15-2(Hazardous Substances Data)

Upstream product

• 149353-75-3 4-(1-(tert-butoxycarbonyl)piperidin-4-yl)benzoic acid 
• 245056-66-0 N-(4-chloropyridin-2-yl)acetamide 
• 19798-80-2 2-Amino-4-chloropyridine 
• 1622205-43-9 tert-butyl 4-(4-((4-((6-ethoxy-1-(methylcarbamoyl)-1H-indol-5-yl)oxy)pyridin-2-yl) carbamoyl)phenyl)piperidine-1-carboxylate 
• 1622205-42-8 5-((2-aminopyridin-4-yl)oxy)-6-ethoxy-N-methyl-1H-indole-1-carboxamide 
• 1622205-41-7 4-((6-ethoxy-1H-indol-5-yl)oxy)pyridin-2-amine 
• 1622205-40-6 N-(4-((6-ethoxy-1H-indol-5-yl)oxy)pyridin-2-yl)acetamide 
• 1622205-39-3 6-ethoxy-1H-indol-5-ol 
• 1622205-38-2 (E)-2-(benzyloxy)-1-ethoxy-4-(2-nitrovinyl)benzene 
• 26691-25-8 3-(benzyloxy)-4-ethoxybenzaldehyde 
• 2539-53-9 4-ethoxy-3-hydroxybenzaldehyde 
• 139-85-5 3,4-dihydroxybenzaldehyde 
• 1622204-14-1 6-ethoxy-N-methyl-5-((2-(4-(piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-1H-indole-1-carboxamide 
• 75-07-0 acetaldehyde 

Relevant articles and documents

MONOCYCLIC PYRIDINE DERIVATIVE

The present invention provides a novel compound having FGFR inhibitory activity or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same. Specifically, the present invention provides a compound represented by the following formula (I) or a pharmaceutically acceptable salt thereof: wherein n represents 0 to 2; A represents an arylene group or a heteroarylene group; G represents a single bond, an oxygen atom or —CH2—; E represents a nitrogen-containing non-aromatic heterocycle; R1 represents an alkoxy group or the like; R2 represents a hydrogen atom or the like; and R3 represents a hydrogen atom, an alkyl group, an alkoxy group or the like, with the proviso that when E represents an azetidine ring and R2 or R3 is present on a nitrogen atom on the azetidine ring, the R2 or R3 does not represent a hydrogen atom.